LeMaitre Vascular Past Earnings Performance
Past criteria checks 5/6
LeMaitre Vascular has been growing earnings at an average annual rate of 11.4%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 12.4% per year. LeMaitre Vascular's return on equity is 11.8%, and it has net margins of 18.3%.
Key information
11.4%
Earnings growth rate
8.4%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 12.4% |
Return on equity | 11.8% |
Net Margin | 18.3% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Investors Met With Slowing Returns on Capital At LeMaitre Vascular (NASDAQ:LMAT)
Sep 17LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Price In Tune With Earnings
Sep 04If EPS Growth Is Important To You, LeMaitre Vascular (NASDAQ:LMAT) Presents An Opportunity
Aug 22LeMaitre Vascular: A Small Cap With Best-In-Industry Growth
Jul 23Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$85.0 Based On Its Intrinsic Value?
Jul 12Is There Now An Opportunity In LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Jun 18Return Trends At LeMaitre Vascular (NASDAQ:LMAT) Aren't Appealing
Jun 05LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Popularity With Investors Is Clear
May 02Is Now The Time To Put LeMaitre Vascular (NASDAQ:LMAT) On Your Watchlist?
Apr 04Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Feb 29What Does LeMaitre Vascular, Inc.'s (NASDAQ:LMAT) Share Price Indicate?
Jan 19Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Paint A Concerning Picture
Oct 27Is It Too Late To Consider Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT)?
Oct 11Does LeMaitre Vascular (NASDAQ:LMAT) Deserve A Spot On Your Watchlist?
Aug 30The Returns On Capital At LeMaitre Vascular (NASDAQ:LMAT) Don't Inspire Confidence
Jul 06Is LeMaitre Vascular, Inc. (NASDAQ:LMAT) Worth US$62.3 Based On Its Intrinsic Value?
May 20Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Mar 12Should You Think About Buying LeMaitre Vascular, Inc. (NASDAQ:LMAT) Now?
Oct 23Calculating The Fair Value Of LeMaitre Vascular, Inc. (NASDAQ:LMAT)
Oct 05LeMaitre Vascular (NASDAQ:LMAT) Could Be Struggling To Allocate Capital
Sep 13LeMaitre Vascular: Reiterate Buy Thesis Following Strong Q2 Numbers
Sep 08LeMaitre Vascular goes ex dividend tomorrow
Aug 23Revenue & Expenses Breakdown
How LeMaitre Vascular makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 206 | 38 | 77 | 17 |
31 Mar 24 | 200 | 34 | 75 | 17 |
31 Dec 23 | 193 | 30 | 73 | 17 |
30 Sep 23 | 186 | 27 | 70 | 16 |
30 Jun 23 | 177 | 25 | 68 | 15 |
31 Mar 23 | 169 | 21 | 65 | 14 |
31 Dec 22 | 162 | 21 | 62 | 13 |
30 Sep 22 | 160 | 21 | 60 | 13 |
30 Jun 22 | 160 | 22 | 58 | 13 |
31 Mar 22 | 158 | 27 | 55 | 12 |
31 Dec 21 | 154 | 27 | 53 | 12 |
30 Sep 21 | 152 | 28 | 51 | 11 |
30 Jun 21 | 151 | 29 | 49 | 10 |
31 Mar 21 | 135 | 24 | 46 | 10 |
31 Dec 20 | 129 | 21 | 46 | 10 |
30 Sep 20 | 122 | 19 | 47 | 10 |
30 Jun 20 | 115 | 16 | 48 | 10 |
31 Mar 20 | 119 | 18 | 50 | 10 |
31 Dec 19 | 117 | 18 | 49 | 9 |
30 Sep 19 | 115 | 19 | 48 | 9 |
30 Jun 19 | 111 | 18 | 47 | 9 |
31 Mar 19 | 108 | 23 | 46 | 9 |
31 Dec 18 | 106 | 23 | 45 | 8 |
30 Sep 18 | 103 | 21 | 44 | 7 |
30 Jun 18 | 104 | 22 | 44 | 7 |
31 Mar 18 | 103 | 18 | 43 | 7 |
31 Dec 17 | 101 | 17 | 43 | 7 |
30 Sep 17 | 98 | 15 | 43 | 7 |
30 Jun 17 | 96 | 14 | 43 | 6 |
31 Mar 17 | 93 | 12 | 42 | 6 |
31 Dec 16 | 89 | 11 | 40 | 6 |
30 Sep 16 | 86 | 11 | 39 | 6 |
30 Jun 16 | 82 | 9 | 38 | 6 |
31 Mar 16 | 79 | 9 | 37 | 6 |
31 Dec 15 | 78 | 8 | 37 | 5 |
30 Sep 15 | 76 | 7 | 36 | 5 |
30 Jun 15 | 74 | 6 | 36 | 5 |
31 Mar 15 | 73 | 5 | 36 | 4 |
31 Dec 14 | 70 | 4 | 36 | 5 |
30 Sep 14 | 70 | 3 | 36 | 5 |
30 Jun 14 | 67 | 3 | 36 | 5 |
31 Mar 14 | 65 | 2 | 36 | 5 |
31 Dec 13 | 64 | 3 | 35 | 5 |
30 Sep 13 | 61 | 3 | 34 | 5 |
Quality Earnings: LMAT has high quality earnings.
Growing Profit Margin: LMAT's current net profit margins (18.3%) are higher than last year (14.2%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: LMAT's earnings have grown by 11.4% per year over the past 5 years.
Accelerating Growth: LMAT's earnings growth over the past year (49.4%) exceeds its 5-year average (11.4% per year).
Earnings vs Industry: LMAT earnings growth over the past year (49.4%) exceeded the Medical Equipment industry 7.2%.
Return on Equity
High ROE: LMAT's Return on Equity (11.8%) is considered low.